Related Experiment Video
Updated: Apr 29, 2026

In Vitro Assay to Study Tumor-macrophage Interaction
Published on: August 1, 2019
Macrophages associated with tumors as potential targets and therapeutic intermediates
Serguei Vinogradov1, Galya Warren, Xin Wei
1Department of Pharmaceutical Sciences, College of Pharmacy, University of Nebraska Medical Center, Omaha, NE 68198-6025, USA.
Abstract:
Tumor-associated macrophages (TAMs) form approximately 50% of tumor mass. TAMs were shown to promote tumor growth by suppressing immunocompetent cells, inducing neovascularization and supporting cancer stem cells. TAMs retain mobility in tumor mass, which can potentially be employed for better intratumoral biodistribution of nanocarriers and effective tumor growth inhibition. Due to the importance of TAMs, they are increasingly becoming principal targets of novel therapeutic approaches. In this review, we compare features of macrophages and TAMs that are essential for TAM-directed therapies, and illustrate the advantages of nanomedicine that are related to the preferential capture of nanocarriers by Mϕ in the process of drug delivery. We discuss recent efforts in reprogramming or inhibiting tumor-protecting properties of TAMs, and potential strategies to increase efficacy of conventional chemotherapy by combining with macrophage-associated delivery of nanodrugs.
Insights
Tumor-associated macrophages (TAMs) are key drivers of tumor growth. Targeting TAMs with nanomedicine offers a promising strategy for enhancing cancer therapy and inhibiting tumor progression.
Area of Science:
- Immunology
- Oncology
- Nanomedicine
Background:
- Tumor-associated macrophages (TAMs) constitute a significant portion of the tumor mass, actively promoting tumor progression by suppressing immune responses, promoting angiogenesis, and supporting cancer stem cells.
- The inherent mobility of TAMs within tumors presents a potential avenue for improving the distribution of nanocarriers and achieving effective tumor growth inhibition.
Purpose of the Study:
- To compare the characteristics of macrophages and TAMs relevant for TAM-directed cancer therapies.
- To highlight the advantages of nanomedicine in drug delivery, particularly the preferential uptake of nanocarriers by macrophages.
- To review current strategies for reprogramming or inhibiting the tumor-promoting functions of TAMs and explore combination therapies with nanodrugs.
Main Methods:
- Comparative analysis of macrophage and TAM features.
- Review of nanomedicine applications in drug delivery and cancer therapy.
- Discussion of recent research on TAM reprogramming and inhibition strategies.
Main Results:
- TAMs play a critical role in tumor growth and progression.
- Nanomedicine offers advantages for targeted drug delivery to TAMs.
- Strategies exist to modulate TAM functions and enhance chemotherapy efficacy.
Conclusions:
- Targeting TAMs is a crucial strategy in novel cancer therapeutics.
- Nanomedicine-based approaches show significant potential for TAM-directed therapies.
- Combining nanodrug delivery with conventional chemotherapy could improve treatment outcomes.
Related Concept Videos
The Tumor Microenvironment
The Tumor Microenvironment
Targeted Cancer Therapies
There are several types of targeted therapies against...
Tumor Immunotherapy

